Literature DB >> 26722463

miR-143 down-regulates TLR2 expression in hepatoma cells and inhibits hepatoma cell proliferation and invasion.

Xing Liu1, Junling Gong2, Baoli Xu3.   

Abstract

Hepatoma is a tumor with high degree of malignancy. A number of oncogenes and tumor suppressor genes play certain roles in tumorigenesis and progression. Among which, miRNA, as an important class of gene regulators, play important roles in regulating tumorigenesis and development of hepatoma. So know well the unique molecular pathway is very important. Here, we showed that there is a different miR-143 expression patterns in different hepatoma tissues, and that miR-143 expressions contribute disease progress. By contrast, we down-regulated the expression of miR-143 with miR-143 mimics in HepG2 cells resulting in decreased proliferation. And the decreased proliferations of HepG2 cells were due to a G0/G1 arrest of cell cycle. During this progress, the increased apoptosis may be another major cause for decreased proliferation of HepG2 cells. And then, we found miR-143 down-regulation induced decreased mRNA and protein expressions of TLR2 and NF-κB. These results show that HepG2 cells depend to a greater extent on miR-143 for proliferation, and miR-143 down-regulation may induce a cell cycle arrest though TLR and NF-κB pathway. miR-143 blockade may be beneficial in therapy of Hepatoma.

Entities:  

Keywords:  TLR2; hepatoma; invasion; miR-143; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26722463      PMCID: PMC4680408     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors:  Guobin He; Michael Karin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  mir-143 and it's emerging role as a modulator of systemic carcinogenesis.

Authors:  Shailendra Kapoor
Journal:  Cell Biochem Biophys       Date:  2014-04       Impact factor: 2.194

3.  Alteration of the microRNA expression profile during the activation of pancreatic stellate cells.

Authors:  Atsushi Masamune; Eriko Nakano; Shin Hamada; Tetsuya Takikawa; Naoki Yoshida; Tooru Shimosegawa
Journal:  Scand J Gastroenterol       Date:  2014-01-10       Impact factor: 2.423

4.  miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

Authors:  Bin Xu; Xiaobing Niu; Xiangxiang Zhang; Jun Tao; Deyao Wu; Zidun Wang; Pengchao Li; Wei Zhang; Hongfei Wu; Ninghan Feng; Zengjun Wang; Lixin Hua; Xinru Wang
Journal:  Mol Cell Biochem       Date:  2011-01-01       Impact factor: 3.396

5.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome.

Authors:  Kerry M Bauer; Amanda B Hummon
Journal:  J Proteome Res       Date:  2012-08-27       Impact factor: 4.466

6.  Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.

Authors:  Xiao-li Zeng; Shao-yan Zhang; Jun-fang Zheng; Hui Yuan; Yan Wang
Journal:  Chin Med J (Engl)       Date:  2013-12       Impact factor: 2.628

Review 7.  Biotherapy for autoimmune liver diseases.

Authors:  Mei Liu; Yu Chen; Sujun Zheng; Zhongping Duan; Jian-Ying Zhang
Journal:  Curr Pharm Biotechnol       Date:  2014       Impact factor: 2.837

8.  The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.

Authors:  Xiaoyin Zhao; Dan Liu; Wei Gong; Guangfeng Zhao; Liu Liu; Liu Yang; Yayi Hou
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

9.  MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer.

Authors:  Jiaojiao Su; Hongwei Liang; Weiyan Yao; Nan Wang; Suyang Zhang; Xin Yan; Hui Feng; Wenjing Pang; Yanbo Wang; Xueliang Wang; Zhen Fu; Yanqing Liu; Chihao Zhao; Junfeng Zhang; Chen-Yu Zhang; Ke Zen; Xi Chen; Yalei Wang
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

10.  Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.

Authors:  Yanxia Chen; Cailing Ma; Wei Zhang; Zhifang Chen; Li Ma
Journal:  Diagn Pathol       Date:  2014-04-28       Impact factor: 2.644

View more
  17 in total

Review 1.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

2.  MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer.

Authors:  L L Zhou; J L Dong; G Huang; Z L Sun; J Wu
Journal:  Braz J Med Biol Res       Date:  2017-07-20       Impact factor: 2.590

3.  RNA-binding protein RBM3 prevents NO-induced apoptosis in human neuroblastoma cells by modulating p38 signaling and miR-143.

Authors:  Hai-Jie Yang; Fei Ju; Xin-Xin Guo; Shuang-Ping Ma; Lei Wang; Bin-Feng Cheng; Rui-Juan Zhuang; Bin-Bin Zhang; Xiang Shi; Zhi-Wei Feng; Mian Wang
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

Review 4.  Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies.

Authors:  Ian F Caplan; Kathleen A Maguire-Zeiss
Journal:  Front Pharmacol       Date:  2018-05-04       Impact factor: 5.810

5.  MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1.

Authors:  Lei Chang; Dongya Zhang; Huirong Shi; Yangyang Bian; Ruixia Guo
Journal:  Oncotarget       Date:  2017-09-16

Review 6.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

7.  MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.

Authors:  Yalda Baghay Esfandyari; Mohammad Amin Doustvandi; Mohammad Amini; Behzad Baradaran; Sheyda Jodeiry Zaer; Nazila Mozammel; Mehdi Mohammadzadeh; Ahad Mokhtarzadeh
Journal:  Reprod Sci       Date:  2021-02-10       Impact factor: 3.060

Review 8.  Angiogenesis-related non-coding RNAs and gastrointestinal cancer.

Authors:  Zahra Sadat Razavi; Kasra Asgarpour; Maryam Mahjoubin-Tehran; Susan Rasouli; Haroon Khan; Mohammad Karim Shahrzad; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-05-15       Impact factor: 7.200

9.  MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN.

Authors:  Zun-Ping Ke; Peng Xu; Yan Shi; Ai-Mei Gao
Journal:  Oncotarget       Date:  2016-05-17

10.  miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.

Authors:  Yun-Peng Jin; Yun-Ping Hu; Xiang-Song Wu; Yao-Shi Wu; Yuan-Yuan Ye; Huai-Feng Li; Yong-Chen Liu; Lin Jiang; Fa-Tao Liu; Yi-Jian Zhang; Ya-Juan Hao; Xi-Yong Liu; Ying-Bin Liu
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.